Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Previously Published Works bannerUCLA

Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View